Captopril in diuretic-treated hypertensive patients

Area of Science:

• Cardiology
• Pharmacology

Background:

• Hypertension management often involves diuretic therapy.
• Assessing the efficacy and predictability of antihypertensive medications is crucial.

Purpose of the Study:

• To evaluate the dose-response relationship and duration of action of captopril in hypertensive patients on diuretics.
• To assess the impact of captopril on plasma renin activity (PRA) and plasma aldosterone concentration (PAC).
• To determine if initial captopril response predicts maintenance requirements.

Main Methods:

• Eight hypertensive patients with normal renal function, on diuretic therapy, received escalating doses of captopril (6.25, 12.5, 25 mg).
• Blood pressure (BP), pulse rate, PRA, and PAC were measured before and after captopril administration.
• Maximal BP decline and duration of BP reduction were recorded.

Main Results:

• Captopril induced a significant maximal decline in BP within 70 minutes of each dose.
• The duration of a ≥10 mm Hg BP decrease was markedly prolonged with increasing captopril doses.
• PRA levels increased, while PAC levels decreased post-captopril administration.
• Transient dizziness occurred in two patients; captopril was otherwise well tolerated.

Conclusions:

• Captopril demonstrates dose-dependent and prolonged blood pressure-lowering effects in hypertensive patients on diuretics.
• The observed changes in PRA and PAC suggest captopril's mechanism of action.
• Initial response to captopril may be a useful predictor for determining long-term therapeutic needs.